Article
Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts.
Journal for immunotherapy of cancer - 1 Jan 2021
Woolaver Rachel A, Wang Xiaoguang, Krinsky Alexandra L, Waschke Brittany C, Chen Samantha M Y, Popolizio Vince, Nicklawsky Andrew G, Gao Dexiang, Chen Zhangguo, Jimeno Antonio, Wang Xiao-Jing, Wang Jing Hong
Abstract excerpt
BACKGROUND: Antitumor immunity is highly heterogeneous between individuals; however, underlying mechanisms remain elusive, despite their potential to improve personalized cancer immunotherapy. Head and neck squamous cell carcinomas (HNSCCs) vary significantly in immune infiltration and therapeutic responses between patients, demanding a mouse model with appropriate heterogeneity to investigate mechanistic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
